-
- Target
- Methylglyoxal (MG)
- Reaktivität
- Bitte anfragen
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Spezifität
- Specific for MG-modified protein (especially Argpyrimidine).
- Aufreinigung
- Protein A purified
- Immunogen
- MG modified keyhole-limpet hemocyanin.
- Klon
- 3C
- Isotyp
- IgG2a
-
anti-Methylglyoxal (MG) antibody
ELISA, WB, FACS, ICC, IF, IHC Wirt: Maus Monoclonal 9E7 unconjugated
anti-Methylglyoxal (MG) antibody (Alkaline Phosphatase (AP))ELISA, WB, FACS, ICC, IF, IHC Wirt: Maus Monoclonal 9E7 Alkaline Phosphatase (AP)
anti-Methylglyoxal (MG) antibody (HRP)ELISA, WB, FACS, ICC, IF, IHC Wirt: Maus Monoclonal 9E7 HRP
anti-Methylglyoxal (MG) antibody (FITC)ELISA, WB, FACS, ICC, IF, IHC Wirt: Maus Monoclonal 9E7 FITC
anti-Methylglyoxal (MG) antibody (Biotin)ELISA, WB, FACS, ICC, IF, IHC Wirt: Maus Monoclonal 9E7 Biotin
anti-Methylglyoxal (MG) antibody (PE)ELISA, WB, FACS, ICC, IF, IHC Wirt: Maus Monoclonal 9E7 PE
anti-Methylglyoxal (MG) antibody (APC)ELISA, WB, FACS, ICC, IF, IHC Wirt: Maus Monoclonal 9E7 APC
anti-Methylglyoxal (MG) antibody (PerCP)ELISA, WB, FACS, ICC, IF, IHC Wirt: Maus Monoclonal 9E7 PerCP
anti-Methylglyoxal (MG) antibody (Atto 594)ELISA, WB, FACS, ICC, IF, IHC Wirt: Maus Monoclonal 9E7 Atto 594
anti-Methylglyoxal (MG) antibody (Atto 488)ELISA, WB, FACS, ICC, IF, IHC Wirt: Maus Monoclonal 9E7 Atto 488
-
- Applikationshinweise
- IHC: 0.5-1.0 ug/mL on paraformaldehyde fixed tissue. User should determine optimum titer for each application.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid: 100 ug IgG/mL in 10 mM PBS containing 0.1 %NaN 3 and 0.5 % BSA. Protein A purified.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- Methylglyoxal (MG)
- Substanzklasse
- Chemical
- Hintergrund
- Methylglyoxal (MG), an endogenous metabolite that increases in diabetes and is a common intermediate in the Maillard glycation reaction. MG reacts with proteins and forms advanced glycation end products (AGEs). MG reacts with residues in proteins and forms numerous adducts,such as argpyrimidine.
-
Sie sind hier:
